Becker, KJ et al. Proc. Natl. Acad. Sci. (USA) vol. 94 pp. 10873-10878, Sep., 1997. |
Kitamura, K et al. Biochim. Biophys. Acta. 379:582-591, 1975. |
Tisch, R and McDevitt, HO. Proc. Nat. Acad. Sci. (USA) 91:437-438, Jan. 1994. |
Brostoff, S. et al. Nature. 235:210-212, Feb. 1972. |
Al-Sabbagh, A. et al. in: Autoimmune Disease Models: A Guidebook. Cohen and Miller, eds. Academic Press, San Diego, pp. 15-22, 1994. |
Brocke, S. et al. in: Autoimmune Disease Models: A Guidebook. Cohen and Miller, eds. Academic Press, San Diego, pp. 1-14, 1994. |
Gregorian, SK. et al. Cellular Immunology. 150:298-310, Sep. 1993. |
Day, MJ. et al. J. Neuroimmunol. 34(2-3):197-203, Nov. 1991. |
Weiner et al., "Double-Blind Pilot Trial of Oral Tolerization With Myelin Antigens in Multiple Sclerosis", Science, vol. 259. Feb. 26, 1993, pp. 1321-1324. |
Weiner, "Oral Tolerance For The Treatment of Autoimmune Diseases", Annu. Rev. Med. 1997, 48:341-51. |
Wang et al., "Myelin antigen reactive T cells in cerebrovascular diseases", Clin. exp. Immunol. (1992) 88, 157-162. |
Hohol et al., "Three-year Open Protocol Continuation Study of Oral Tolerization With Myelin Antigens in Multiple Sclerosis and Design of a Phase III Pivotal Trial", Annals New York Acad. of Science, vol. 778, 1996, pp. 243-250. |
Al-Sabbagh et al., "Decreased CNS Inflammation and Absence of Clinical Exacerbation of Disease After Six Months Oral Administration of Bovine Myelin in Diseases SJL/J Mice With Chronic Relapsing Experimental Autoimmune Encephalomyelitis", Journal of Neuroscience Research 45:424-429 (1996). |
Mandai et al., "Ischemic Damage And Subsequent Proliferation of Oligodendrocytes in Focal Cerebral Ischemia", Neuroscience vol. 77, No. 3, pp. 849-861, 1997. |
Kelly et al., "Oral tolerance in EAE: reversal of tolerance by T helper cell cytokines", Journal of Neuroimmunology 66 (1996) 77-84. |